CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Adalimumab

Last Updated: December 23, 2013
Result type: Reports
Project Number: SR0365-000
Product Line: Reimbursement Review

Generic Name: Adalimumab

Brand Name: Humira

Manufacturer: AbbVie

Therapeutic Area: ulcerative colitis

Indications: Ulcerative colitis

Submission Type: Initial

Project Status: Withdrawn